FDA Inspection
Alembic Pharmaceuticals Ltd (API Division, Karakhadi)Alembic Pharmaceuticals Ltd (API Division, Karakhadi) – FDA Inspection, May 18, 2018
Record Details
This FDA Inspection record concerns Alembic Pharmaceuticals Ltd (API Division, Karakhadi), with an inspection on May 18, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 18, 2018
- Product Type
- Drugs
View Company Profile
ID · 22b2fcb7-8910-4475-a524-060847e40dc9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055638
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2025 | Not classified | Office of Inspections and Investigations | |
| April 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
- FDA Inspection 1267871 - 2025-03-21
- FDA Inspection 927526 - 2015-04-23
- FDA Inspection 830941 - 2013-04-05
- FDA Inspection 712407 - 2011-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.